Organization
Tiziana Borsello PhD
Group Leader
Education
- BA(Hons) Biology, University of Turin, Italy 1990
- PhD University of Turin, Italy 1995
Appointments
- 1997-1999 Researcher at the Institute of Neurobiology, CNR, Rome with Prof. P. Calissano.
- 1999-2003 Premier Assistant, Département de Biologie Cellulaire et de Morphologie, Université de Lausanne, Switzerland, with Prof. P. Clarke.
- Group Leader at the DBCM, University of Lausanne, Switzerland, since 2003.
- Unit Leader of Neuronal death and Neuroprotection at the Istituto di ricerche Farmacologiche "Mario Negri", Italy, 2004.
Recent Prizes
- Prize of the Pfizer Foundation, Neuroscience and Diseases Nervous System 2005
- Prize of SGAHE Morphology 2004
- A Peptide Inhibitor Of C-Jun N-Terminal Kinase Protects Against Excitotoxicity And Cerebral Ischemia. Nat Med., 2003 has been recently identified by Essential Science Indicators as the highest cited paper in the research area of "INFLAMMATION-MEDIATED NEURODEGENERATION”
Xenia Antoniou, PhD
Post-doc
Of Greek nationality, Xenia carried out her BSc/MSc studies in London, UK. Thereafter she did her PhD at the University of Zurich, Switzerland. Her research interests focus on the elucidation of signalling pathways with a key role in neuroprotection.
Andrea Arnaboldi
Student
andrea.arnaboldi@marionegri.it
Andrea is studying to obtain his BSC in Pharmaceutical Chemistry and Technology at the University of Milan. He is interested in the study of the role of JNK in the induction of synaptic toxicity. In particular he is evaluating the modifications in morphology and density of dendritic spines in hippocampal neurons treated with oligomeric forms of ABeta at different states of aggregation.
Federica Morelli
PhD Student
federica.morelli@marionegri.it
Federica obtained the BSc in Industrial-Environmental Biotechnologies at the University of Milan in 2006. She worked at the Sperimental Oncology Department, “IRCCS National Institute of Tumors”, Milan. Her project is now focused on the JNK3 pathway’s role in AD pathology.
Isabella Colombo
Student
isabella.colombo@marionegri.it
Isabella is studying to obtain her BSc in Pharmaceutical Chemistry and Technology at the University of Milan. She is studying the role of JNK pathway in the induction of synaptic toxicity focusing on the pre-synaptic compartment.
Alessandra Sclip
Ph.D Student
Alessandra obtained the BSc in Pharmaceutical Biotechnologies at the University of Milan in 2007. She is currently doing her PhD within the PhD program of The “Open University”. Her research interests are focused on the study of amyloid beta oligomers effect on MAPKs pathways and their contribution to the genesis of synaptopathies.
Paola Roderi
Student
Paola is studying to obtain her BSC in Pharmaceutical Biotechnologies at the University of Milan. She is working on JNK3 signaling in stress condition.
Agata Camassa
Student
Agata is a student at University of Milan and she is finishing her studies to obtain a Pharmacy BSc. Agata joined our lab for her thesis and she is focused on studying SUMOylation on several proteins occurring during synaptic and neuronal death. At the moment she is involved in studying JNK3 signalling pathway.
Elisa Brambilla
Student
Elisa is studying to obtain her BSc in Molecular Biology at Bicocca University in Milan. Her thesis is focused on protein SUMOylation process that occurs at neuronal level. She is particulary interested in understanding a possible neuroprotective role of SUMO in apoptosis event.
Matteo Sacchi
Researcher
After graduating in Medicine and Surgery, Matteo trained as Resident in Ophthalmology at the University of Milan. He completed your training program working at the Eye Department of Rochester University and in Bascom Palmer Eye Institute, Miami. He is currently working at the University Eye Clinic of San Giuseppe Hospital, Milan as Ophthalmologist. Matteo joined our Lab to explore the role of JNK pathways in ophthalmology and is currently involved in a study investigating the role of D-JNKI1 in an animal model of high-risk cornea transplant and glaucoma.